---
schema_version: "secwatch.filing_event.v1"
accession: "0001370053-26-000002"
form_type: "8-K"
ticker: "ANAB"
cik: "0001370053"
company_name: "ANAPTYSBIO, INC"
filed_at: "2026-01-09T23:59:59+00:00"
generated_at: "2026-05-16T11:02:33.727741+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# AnaptysBio reports preliminary cash & investments of ~$310M as of Dec 31, 2025

## Summary
- Preliminary unaudited cash, equivalents and investments ~$310M as of Dec 31, 2025.
- Audited FY2025 financials not yet available; final results may differ materially.
- Disclosure to be made at J.P. Morgan Healthcare Conference on January 11, 2026.

## SEC filing metadata
- accession: 0001370053-26-000002
- form_type: 8-K
- ticker: ANAB
- cik: 0001370053
- company_name: ANAPTYSBIO, INC
- filed_at: 2026-01-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1370053/000137005326000002/0001370053-26-000002-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1370053/000137005326000002/anab-20260109.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001370053-26-000002
- JSON: https://secwatch.observer/filing/0001370053-26-000002.json
- Plain text: https://secwatch.observer/filing/0001370053-26-000002.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.